Subscribe to Christianity Today
Subscribe to Christianity Today
Donate to Christianity Today
login | my account
February 12, 2012

Home > 2003 > MarchChristianity Today, March, 2003
Abortion pill critic named to drug panel
David Hager appointed to committee despite criticism from prochoice camps

President Bush has named W. David Hager, a vocal critic of the abortion pill Mifepristone, to the Food and Drug Administration's Advisory Committee for Reproductive Health Drugs. Bush appointed Hager (a prominent member of the Christian Medical Association) and 10 others on December 24.

The committee will evaluate the effectiveness and safety of drugs that obstetricians and gynecologists.

The CMA is petitioning the FDA to re-examine the approval process for Mifepristone, or RU-486, which the association calls unsafe. Prochoice groups accuse the Kentucky physician of religious extremism.

Supporters, such as the Family Research Council, say Hager is a victim of religious profiling for his prolife views (CT, Dec, 9, 2002, p.15). Pia De Solenni, an ethicist with FRC's Center for Human Life and Bioethics, told Christianity Today, "We're not the ones putting out a litmus test."

Hager told CT that pro-choice are calling for his resignation. "There's still an outcry from pro-abortion forces to get me to resign," Hager said. "I don't intend to resign."

If the panel were to make a decision about Mifepristone, Hager said, he would recuse himself from the vote of his high public profile on the issue.

Hager said he will continue to evaluate all data objectively. "It's my firm belief that a person of faith can be a person of science," he said.


Related Elsewhere


Previous Christianity Today articles include:

FDA Candidate Irks Abortion Pill Advocates | The Christian Medical Association says critics fear David Hager's "well-grounded" opposition. (Nov. 26, 2002)
Counteroffensive Launched on RU-486 | Abortion-pill critics allege safety concerns overlooked in FDA approval process. (June 15, 2001)

Related coverage includes:

Bush FDA Nominee Cites Safety ...
This article is currently available to CT subscribers only. To continue reading:




Christianity Today


  


Subscribe to Christianity Today and get 3 free trial issues. No credit card required.

Please allow 4-6 weeks for delivery. Offer valid in U.S. only.

If you decide you want to keep Christianity Today coming, honor your invoice for just $19.95 and receive nine more issues, a full year in all. If not, simply write "cancel" across the invoice and return it. The three trial issues are yours to keep, regardless.


Click here for international orders2-for-1 Gifts!

You must be a Christianity Today subscriber or have created a FREE registration to post comments
[Browse More Christianity Today]



Search
Search
Search
Scripture Search
Go Deeper

Books & Culture
Christianity Today
Church Law & Tax Report
Church Finance Today
Leadership Journal
Men of Integrity
Kyria.com
ChristianityTodayLibrary.com
PreachingToday.com